Related Articles
Torilis japonica extract, a new potential EMT suppressor agent by regulation of EGFR signaling pathways
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer
The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells
Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo